Peptide LexiconAll compounds

Calcitonin: The 32-Amino-Acid Thyroid Hormone — and Why the Medicine Is Made From Salmon's Version

Calcitonin is a 32-amino-acid hormone made by the thyroid's C cells that briefly lowers blood calcium. The medicine is salmon calcitonin, which differs from the human hormone at 16 of 32 positions. It is approved for Paget's disease, hypercalcaemia and postmenopausal osteoporosis, with fracture reduction not demonstrated and a malignancy warning.

Made by the body32 amino acidsCalcitonin salmon FDA-approved (Miacalcin, NDA 017808)

Caroline S · Published 2026-10-04

Length

32 amino acids, with a ring closed by a disulfide bond between positions 1 and 7 and an amidated proline at the end

Sequence

Human: CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2, residues 85–116 of a 141-residue precursor (UniProt P01258). Salmon: CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-NH2 (UniProt P01263, chum salmon) — 16 of the 32 positions differ

Origin

Made by the parafollicular (C) cells of the thyroid gland in mammals, and by the ultimobranchial gland in birds and fish (Miacalcin label). The same precursor also yields a second peptide, katacalcin (21 amino acids).

Last reviewed

2026-10-05

What is it good for?

In the body, a rapid but short-lived drop in blood calcium and phosphate, by pushing those minerals into bone (UniProt P01258). As a medicine, calcitonin salmon is approved for symptomatic Paget's disease of bone and postmenopausal osteoporosis when alternatives are not suitable, and for hypercalcaemia. The label states fracture reduction has not been demonstrated.

Illustration: An empty, clear glass Erlenmeyer flask with a stopper on a white lab bench, with green and copper accents.
Illustration

What it is

Calcitonin is a 32-amino-acid hormone made by the thyroid gland. It comes from the thyroid's parafollicular cells, often called C cells, which sit between the follicles that make thyroid hormone. UniProt's record for human calcitonin (P01258) places it at residues 85–116 of a 141-residue precursor:

  • sequence CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP;
  • a ring closed by a disulfide bond between the cysteines at positions 1 and 7;
  • an amidated proline at the end.

The same precursor yields a second peptide, katacalcin (21 amino acids), which UniProt also annotates as lowering plasma calcium. The uncut 116-residue chain that both are trimmed from leaks into the blood in bacterial infection and is measured in hospitals as the procalcitonin test.

What it does

UniProt's function annotation: calcitonin causes a rapid but short-lived drop in blood calcium and phosphate by promoting their incorporation into bone. It acts through the calcitonin receptor (CALCR) and through a receptor complex of CALCR with the accessory protein RAMP2 — one of the receptors amylin also uses. Calcium is otherwise managed mainly by parathyroid hormone, whose drug fragments are recorded in teriparatide and abaloparatide.

Why the medicine is salmon's

The medicine is calcitonin salmon, a synthetic copy of the hormone fish make in their ultimobranchial gland (Miacalcin label). Set side by side, the two are the same length with the same ring, but differ at 16 of 32 positions:

Sequence (1–32)
Human (UniProt P01258) CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP
Salmon (UniProt P01263) CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP

Because it is a foreign sequence, the label warns that circulating antibodies to calcitonin salmon may develop and may cause loss of response. Its immunogenicity section puts a number on it: antibodies after 2 to 18 months of treatment were reported in about half of the Paget's disease patients in whom antibody studies were done, and patients with high titres usually lost their response. The label adds that the measured rate depends heavily on the assay.

How the injected medicine behaves

The Miacalcin label's pharmacokinetics section (12.3) describes a short-acting peptide:

Measure Label figure
Absolute bioavailability About 66% into muscle, 71% under the skin
Time to peak (under the skin) About 23 minutes
Terminal half-life About 58 minutes into muscle; 59–64 minutes under the skin
Apparent volume of distribution 0.15–0.3 L/kg

A half-life of about an hour matches UniProt's description of the hormone's own effect: a rapid but short-lived drop in calcium.

What the label says

Miacalcin injection (NDA 017808; label effective 2024-09-15) contains 200 USP units per mL for injection under the skin or into muscle. Its label lists:

Indication Stated limit
Symptomatic Paget's disease of bone Moderate to severe disease; when alternatives are not suitable
Hypercalcaemia —
Postmenopausal osteoporosis When alternatives are not suitable; fracture reduction not demonstrated

The label's doses are 100 USP units daily for Paget's disease and osteoporosis, and a weight-based schedule starting at 4 USP units/kg every 12 hours for hypercalcaemia.

Two warnings stand out. Malignancy: in a meta-analysis of 21 randomised controlled trials of calcitonin salmon (nasal spray or investigational oral forms), malignancies were reported in 4.1% of treated patients against 2.9% on placebo, and the label asks for periodic re-evaluation of continued therapy. Hypersensitivity: serious reactions, including deaths from anaphylaxis, have been reported.

Where it stands

Calcitonin salmon remains FDA-listed as Miacalcin injection and as generic injections and nasal sprays (openFDA, 2026-10-04). PubMed returns 41,327 records for calcitonin, 1,031 tagged as randomised controlled trials. The human hormone itself is not sold as a medicine.

Because calcitonin slows bone breakdown, studies of it often track the bone-resorption marker CTX.

The calcitonin gene has a second product: processed differently in nerve tissue, its RNA gives calcitonin gene-related peptide, a 37-amino-acid vessel-widener (Amara and colleagues, Nature, 1982). Calcitonin's closest relative is amylin, whose altered copy is the approved drug pramlintide. For the other side of calcium control, see the parathyroid-hormone fragment teriparatide. Salmon is not the only donor species behind an approved peptide: eptifibatide was modelled on a rattlesnake venom protein. Its opposite number, which raises blood calcium rather than lowering it, is PTH from the parathyroid glands.

What the research shows

Lowers blood calcium and phosphate

UniProt P01258 function annotation, citing the published literature; acts through the calcitonin receptor CALCR

Treats Paget's disease, hypercalcaemia and postmenopausal osteoporosis

Approved indications of Miacalcin injection (label effective 2024-09-15), each with stated limits

Reduces fractures in osteoporosis

No. The label: 'Fracture reduction efficacy has not been demonstrated'

Raises cancer risk

Label section 5.3: in a meta-analysis of 21 randomised trials, malignancies 4.1% on calcitonin salmon vs 2.9% on placebo

Bars show how much of the evidence is in humans, not how well anything works.

Where it stands

In the body

A thyroid C-cell hormone acting through the calcitonin receptor and the CALCR–RAMP2 amylin receptor complex (UniProt P01258).

United States

Calcitonin salmon injection (Miacalcin, NDA 017808) and generic injections and nasal sprays are listed (openFDA, 2026-10-04).

Published record

PubMed returns 41,327 records for calcitonin, 1,031 tagged as randomised controlled trials (2026-10-04).

Frequently asked questions

What is calcitonin?

A 32-amino-acid hormone made by the C cells of the thyroid gland. It causes a rapid but short-lived drop in blood calcium and phosphate by promoting their uptake into bone, acting through the calcitonin receptor.

Why is calcitonin medicine made from salmon?

The approved medicine is a synthetic copy of salmon calcitonin, not the human hormone. The two share their 32-residue length and ring structure but differ at 16 positions. The label describes it as having the same linear sequence as calcitonin of salmon origin.

What is calcitonin used for?

The Miacalcin injection label lists three uses: symptomatic Paget's disease of bone when alternatives are not suitable, hypercalcaemia, and postmenopausal osteoporosis when alternatives are not suitable. For osteoporosis the label states fracture reduction has not been demonstrated.

Does calcitonin cause cancer?

The label reports a possible association. In a meta-analysis of 21 randomised trials, malignancies were reported in 4.1% of calcitonin salmon patients and 2.9% on placebo, and the label asks that the need for continued therapy be re-evaluated periodically.

How long does a calcitonin injection last?

Not long. The Miacalcin label gives a terminal half-life of about 58 minutes after injection into muscle and 59–64 minutes under the skin, with peak blood levels about 23 minutes after a subcutaneous dose.

Is calcitonin related to amylin?

Yes. Amylin, released with insulin, belongs to the same peptide family, and calcitonin can act through an amylin receptor — the calcitonin receptor paired with the accessory protein RAMP2 (UniProt P01258).